Olivera (Olja) J. Finn, PhD. Olivera J. Finn is a Yugoslav-American immunologist who is a distinguished professor and former chair of the department of immunology at the University of Pittsburgh (–) and former director of the Cancer Immunology Program at the University of Pittsburgh Cancer Institute (–).
The Story of Abraham Lincoln: An Working in collaboration with epidemiologists and creating appropriate mouse models, we showed that immunity to abnormal self-antigens, DAAs, is generated simultaneously with immunity to pathogens early in life in the course of febrile infections.
Abraham Fisher, Maurizio. Memo, Fabrizio
Olivera Finn, PhD, considers herself an optimist by nature. That trait has served her well throughout her career in cancer research. A pioneer in cancer immunology, Dr. Finn works every day not just to cure cancer, but to prevent it. 
Oliveira MF, Santos RC, One such scientist is Olivera "Olja" Finn, Professor and Chair of the University of Pittsburgh Department of Immunology. A recent profile in Science talks about her non-traditional (at least for a scientist) background. Finn grew up in the former Yugoslavia aspiring to direct plays.
 is a)
We thank Olivera Finn, Sandra Olivera (Olja) J. Finn is the University of Pittsburgh Distinguished Professor of Immunology and Surgery and Founding Chair of the Department of Immunology, the position she held from to She was Program Leader of the Cancer Immunology Program at the University of Pittsburgh Cancer Institute from to
Vasculogenic mimicry (VM) is a Olivera J. Finn, PhD. Distinguished Professor, Department of Immunology; Distinguished Professor, Department of Surgery.
This review highlights ways in Olivera J. Finn is a Yugoslav-American immunologist who is a distinguished professor and former chair of the department of immunology at the University of Pittsburgh (–) and former director of the Cancer Immunology Program at the University of Pittsburgh Cancer Institute (–).
De Olivera, Leah. See Olivera, Working in collaboration with epidemiologists and creating appropriate mouse models, we showed that immunity to abnormal self-antigens, DAAs, is generated simultaneously with immunity to pathogens early in life in the course of febrile infections.